SysteMHC v.231201
Home Datasets Download Help About Update

Showing details for project SYSMHC00039



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00039_B-ALL_IP_fresh_100M 3 Human HLA-A02:01,HLA-A11:01,HLA-B40:01,HLA-B44:03
SYSMHC00039_B-ALL_IP_frozen_100M 3 Human HLA-A02:01,HLA-A11:01,HLA-B40:01,HLA-B44:03
SYSMHC00039_B-ALL_IP_frozen_20M 3 Human HLA-A02:01,HLA-A11:01,HLA-B40:01,HLA-B44:03
SYSMHC00039_B-ALL_IP_frozen_2M 3 Human HLA-A02:01,HLA-A11:01,HLA-B40:01,HLA-B44:03
SYSMHC00039_B-ALL_MAE_fresh_100M 3 Human HLA-A02:01,HLA-A11:01,HLA-B40:01,HLA-B44:03
SYSMHC00039_B-ALL_MAE_fresh_20M 3 Human HLA-A02:01,HLA-A11:01,HLA-B40:01,HLA-B44:03
SYSMHC00039_B-ALL_MAE_fresh_2M 3 Human HLA-A02:01,HLA-A11:01,HLA-B40:01,HLA-B44:03
SYSMHC00039_B-ALL_MAE_frozen_100M 3 Human HLA-A02:01,HLA-A11:01,HLA-B40:01,HLA-B44:03
SYSMHC00039_B-LCL_IP_fresh_100M 3 Human HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01
SYSMHC00039_B-LCL_IP_frozen_100M 3 Human HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01
SYSMHC00039_B-LCL_IP_frozen_20M 3 Human HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01
SYSMHC00039_B-LCL_IP_frozen_2M 3 Human HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01
SYSMHC00039_B-LCL_MAE_fresh_100M 3 Human HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01
SYSMHC00039_B-LCL_MAE_fresh_20M 3 Human HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01
SYSMHC00039_B-LCL_MAE_fresh_2M 3 Human HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01
SYSMHC00039_B-LCL_MAE_frozen_100M 3 Human HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01



Detailed view of sample SYSMHC00039_B-LCL_IP_frozen_100M



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00039 SYSMHC00039_B-LCL_IP_frozen_100M B-LCL_IP_frozen_100M_1.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 29508533 native Immunoaffinity and mild acid elution W6/32 Q-Exactive HF Easy nLC1000 no DDA HCD 1
SYSMHC00039 SYSMHC00039_B-LCL_IP_frozen_100M B-LCL_IP_frozen_100M_2.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 29508533 native Immunoaffinity and mild acid elution W6/32 Q-Exactive HF Easy nLC1000 no DDA HCD 2
SYSMHC00039 SYSMHC00039_B-LCL_IP_frozen_100M B-LCL_IP_frozen_100M_3.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 29508533 native Immunoaffinity and mild acid elution W6/32 Q-Exactive HF Easy nLC1000 no DDA HCD 3